IMM 5.36% 29.5¢ immutep limited

An announcement would be appropriate to inform investors re...

  1. 4,906 Posts.
    lightbulb Created with Sketch. 343

    An announcement would be appropriate to inform investors re outcome of these discussions whether positive or negative.Cheers


    ASX/Media Release
    Monday 11th May 2009
    PRIMA BIOMED TO COMMENCE DISCUSSIONS WITH POTENTIAL NORTH
    AMERICAN INVESTMENT PARTNERS
    Australian health care company Prima BioMed (Prima) (ASX: PRR) is pleased to
    announce that it will commence discussions with potential major North American
    institutional investment funds later this month for the development of its core product,
    the CVac™ ovarian cancer therapy vaccine.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
29.5¢
Change
0.015(5.36%)
Mkt cap ! $428.5M
Open High Low Value Volume
28.5¢ 30.5¢ 28.0¢ $833.4K 2.824M

Buyers (Bids)

No. Vol. Price($)
8 388130 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 39940 3
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.